CONSULTING AGREEMENTConsulting Agreement • May 10th, 2024 • XORTX Therapeutics Inc. • Pharmaceutical preparations • Ontario
Contract Type FiledMay 10th, 2024 Company Industry Jurisdiction1282803 Ontario Inc., a company incorporated under the laws of the Province of Ontario, Canada, located at 1228 Journeys End Trail, Haliburton, ON, K0M 1S0 (hereinafter called the “Contractor”)
AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • May 10th, 2024 • XORTX Therapeutics Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 10th, 2024 Company Industry JurisdictionThis Consulting Agreement (together with the attached Exhibit A (the “Business Terms Exhibit”), collectively this “Agreement”, is made as of May 1, 2024 (the “Effective Date”) by and between XORTX Therapeutics Inc., a corporation incorporated in British Columbia and located at 3710, 33rd Street, N.W. Calgary, Alberta T2L 2M1 Canada (“Company”), and Stacy Evans, M.D., M.B.A. with an address of 2700 San Pablo Avenue, Suite 309, Berkeley, California 94702 USA (“Consultant”).
CONSULTING AGREEMENTConsulting Agreement • May 10th, 2024 • XORTX Therapeutics Inc. • Pharmaceutical preparations • British Columbia
Contract Type FiledMay 10th, 2024 Company Industry JurisdictionPLUTUS BRIDGE CAPITAL INC., a British Columbia company with an address at Suite 306 - 1110 Hamilton Street, Vancouver, BC V6B 2S2 (the “Consultant”)